February 25, 2022 – Dignity Health in Arizona is launching the first research study in North America in which genetic ...
February 24, 2022 — The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of ...
February 24, 2022 — The Department of Justice, together with Attorneys General in Minnesota and New York, filed a civil ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
February 24, 2022 — Imagine that you are admitted to hospital. A smart scheduling system ensures you have a bed; you ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
February 21, 2022 – Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of ...
February 18, 2022 — GE Healthcare has announced that it has received approval from the European Medicines Agency (EMA) ...
We are launching something new—a Clinical Case of the Month—and we want you to contribute! Do you have a clinical case ...
February 25, 2022
